This was endorsed by the multi-society statementincluding AGA, AASLD, ACG, ASGE and NASPGHANentitled, No data to support stopping GLP-1 agonists prior to elective endoscopy. The Link to Aspiration Pneumonia: Results From Large Population-Based Study The senior author, Ali Rezaie, MDmedical director of the GI Motility Program at Cedars-Sinai Medical Center in Los Angeles, Californiasought to verify through empirical data whether these medications did, in fact, raise the risk of aspiration pneumonia
Company History 8.1.3
Youre focused on endurance performance or metabolic flexibility
Originally developed to treat type 2 diabetes, GLP-1 injections have shown remarkable efficacy in weight management and have been approved for this use in various formulations
Our commitment to providing precise 5 Amino 1mq ensures researchers can confidently explore these mechanisms
Practical differences Injection frequency One of the biggest practical differences between these medications is how often you inject